Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cyclocarya paliurus extract is a botanical preparation derived from the leaves of the Sweet Tea Tree, a species native to China. The extract is rich in bioactive compounds, including polysaccharides, flavonoids, and triterpenoids, which have been investigated for their potential therapeutic effects in metabolic disorders. In the context of type 2 diabetes mellitus, the extract is thought to exert anti-hyperglycemic effects by modulating the gut microbiota, improving insulin sensitivity, and potentially inhibiting carbohydrate-digesting enzymes like alpha-glucosidase. Clinical research, such as studies conducted by The Affiliated Hospital of XiangNan University, has explored its use as an adjunctive therapy to standard oral hypoglycemics like glipizide to enhance glycemic control and metabolic health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cyclocarya paliurus extract.